SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Zentalis Pharmaceuticals Q1 EPS $(2.880) Down From $(1.490) YoY

Zentalis Pharmaceuticals (NASDAQ:ZNTL) reported quarterly losses of $(2.880) per share. This is a 93.29 percent decrease over losses of $(1.490) per share from the same period last year.

Benzinga · 05/15/2020 11:10

Zentalis Pharmaceuticals (NASDAQ:ZNTL) reported quarterly losses of $(2.880) per share. This is a 93.29 percent decrease over losses of $(1.490) per share from the same period last year.